| abstract |
The present invention describes compounds of general formula (I), processes for their preparation, medicaments containing them and their preparation, and the use of these compounds as pharmaceutically active agents. The compounds exhibit activity as protein kinase inhibitors, particularly src family tyrosine kinase inhibitors, and are therefore useful for the treatment of diseases mediated by the tyrosine kinases. |